BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6286775)

  • 1. Generation of long-term human cytolytic cell lines with persistent natural killer activity.
    Krensky AM; Ault KA; Reiss CS; Strominger JL; Burakoff SJ
    J Immunol; 1982 Oct; 129(4):1748-51. PubMed ID: 6286775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations.
    Zarling JM; Dierckins MS; Sevenich EA; Clouse KA
    J Immunol; 1981 Nov; 127(5):2118-23. PubMed ID: 6170690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
    Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
    J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation.
    Storkus WJ; Dawson JR
    J Immunol; 1986 Mar; 136(5):1542-7. PubMed ID: 3081629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a cloned NK cell line derived from the "null cell" fraction of human peripheral blood.
    Hercend T; Meuer S; Reinherz EL; Schlossman SF; Ritz J
    J Immunol; 1982 Sep; 129(3):1299-305. PubMed ID: 7108207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro generation of NK-like activity in human PBL co-cultured with fresh T leukaemia cells.
    Matera L; Foa R; Moore M
    J Clin Lab Immunol; 1984 Oct; 15(2):85-90. PubMed ID: 6335181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct human cloned T cell lines that exhibit natural killer-like and anti-human effector activities.
    Sugamura K; Tanaka Y; Hinuma Y
    J Immunol; 1982 Apr; 128(4):1749-52. PubMed ID: 6120975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of lymphocytes against pooled allogeneic cells. II. Characterization of effector cells cytotoxic for autologous lymphoblastoid cell lines.
    Zarling JM; Bach FH; Kung PC
    J Immunol; 1981 Jan; 126(1):375-8. PubMed ID: 6450239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity and phenotype of IL-2 expanded clones of human large granular lymphocytes.
    Allavena P; Ortaldo JR
    Diagn Immunol; 1983; 1(3):162-7. PubMed ID: 6209054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes.
    Rumpold H; Kraft D; Obexer G; Böck G; Gebhart W
    J Immunol; 1982 Oct; 129(4):1458-64. PubMed ID: 6180009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell surface phenotype of a cloned line of human natural killer cells.
    Kornbluth J; Flomenberg N; Dupont B
    J Immunol; 1982 Dec; 129(6):2831-7. PubMed ID: 6982944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
    Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
    Torsteinsdottir S; Masucci MG; Szigeti R; Bishara A; Brautbar C; Klein G; Klein E
    Mol Biol Med; 1984 Aug; 2(4):285-99. PubMed ID: 6443579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum.
    Lauer SJ; Finlan J; Borella LD; Piaskowski VD; Casper JT
    J Clin Lab Immunol; 1983 Oct; 12(2):105-10. PubMed ID: 6606047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody- and interferon-dependent killer cells are part of the NK cell receptor positive subpopulation of human peripheral blood cells.
    Ullberg M; Jondal M
    Clin Exp Immunol; 1983 Jul; 53(1):101-8. PubMed ID: 6872324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
    Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
    J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.